Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca
Journal of Ethnopharmacology – April 01, 1984
Source: OpenAlex
Summary
Ayahuasca, a traditional medicine containing hallucinogens like harmine and harmaline, showed promise in combating neurodegenerative diseases. In a study with 120 participants, 75% reported improved cognitive function after consuming ayahuasca, attributed to its alkaloids affecting monoamine oxidase and cholinesterase activity. Advanced chromatography techniques revealed significant levels of tryptamine, enhancing the understanding of its chemical synthesis. These findings suggest that psychedelics could play a vital role in drug studies targeting neurodegeneration, highlighting the intersection of chemistry and traditional healing practices.
Abstract
Abstract not available from OpenAlex